Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions

Aerobic exercise attenuates pulmonary injury induced by exposure to cigarette smoke

A.C. Toledo, R.M. Magalhaes, D.C. Hizume, R.P. Vieira, P.J.C. Biselli, H.T. Moriya, T. Mauad, F.D.T.Q.S. Lopes, M.A. Martins
European Respiratory Journal 2012 39: 254-264; DOI: 10.1183/09031936.00003411
A.C. Toledo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R.M. Magalhaes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D.C. Hizume
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R.P. Vieira
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P.J.C. Biselli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H.T. Moriya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Mauad
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F.D.T.Q.S. Lopes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.A. Martins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mmartins@usp.br
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

It has recently been suggested that regular exercise reduces lung function decline and risk of chronic obstructive pulmonary disease (COPD) among active smokers; however, the mechanisms involved in this effect remain poorly understood.

The present study evaluated the effects of regular exercise training in an experimental mouse model of chronic cigarette smoke exposure.

Male C57BL/6 mice were divided into four groups (control, exercise, smoke and smoke+exercise). For 24 weeks, we measured respiratory mechanics, mean linear intercept, inflammatory cells and reactive oxygen species (ROS) in bronchoalveolar lavage (BAL) fluid, collagen deposition in alveolar walls, and the expression of antioxidant enzymes, matrix metalloproteinase 9, tissue inhibitor of metalloproteinase (TIMP)1, interleukin (IL)-10 and 8-isoprostane in alveolar walls.

Exercise attenuated the decrease in pulmonary elastance (p<0.01) and the increase in mean linear intercept (p=0.003) induced by cigarette smoke exposure. Exercise substantially inhibited the increase in ROS in BAL fluid and 8-isoprostane expression in lung tissue induced by cigarette smoke. In addition, exercise significantly inhibited the decreases in IL-10, TIMP1 and CuZn superoxide dismutase induced by exposure to cigarette smoke. Exercise also increased the number of cells expressing glutathione peroxidase.

Our results suggest that regular aerobic physical training of moderate intensity attenuates the development of pulmonary disease induced by cigarette smoke exposure.

  • Aerobic exercise
  • chronic obstructive pulmonary disease
  • cigarette smoke
  • emphysema
  • oxidative stress

Although the majority (80%) of patients with chronic obstructive pulmonary disease (COPD) are cigarette smokers, only a small proportion (15–20%) of cigarette smokers develop COPD [1], suggesting that there are genetic and/or environmental susceptibility factors involved in the development of this syndrome. Recently, Garcia-Aymerich et al. [2] observed that active smokers who practised moderate or high levels of regular physical activity had a reduced risk of developing COPD compared with the low physical activity group. Previous studies have shown that physical exercise increases the resistance against oxidative stress in skeletal muscle [3]. Some epidemiological studies suggest that regular physical exercise reduces the incidence of diseases associated with oxidative stress [4]. This phenomenon is considered a result of adaptation induced by exercise. This process involves the activation of the antioxidant system and redox reactions, and it influences transcription and, thus, gene expression and assembly of proteins [5].

COPD is an important cause of morbidity, mortality and healthcare costs worldwide [6]. Its prevalence is around 9–10% among individuals aged >40 yrs but can reach up to 20% in some areas of the world [1]. Tobacco smoking is the most important risk factor for COPD. Although the pathogenesis of COPD remains incompletely understood, the importance of oxidative stress in lungs and systemic circulation is well established [7]. In the gas phase of cigarette smoke there are high concentrations of many oxidants/free radicals (>1015 molecules per puff) [8]. In addition, there are also endogenous sources of reactive oxygen species (ROS), such as those produced by activated leukocytes recruited to the lungs in response to cigarette smoke. ROS derived from both cigarette smoke and endogenous sources can damage lipids, proteins and nucleic acids and, in some cases, induce the formation of more stable reactive molecules that can prolong the oxidant-mediated damage [9].

The purpose of our study was to evaluate the effects of regular physical training during the establishment of pulmonary alterations induced by chronic (24 weeks’) exposure to cigarette smoke in mice. Our hypothesis was that aerobic conditioning could attenuate the development of pulmonary disease induced by cigarette smoke exposure. Since there is strong evidence that an impairment in oxidant–antioxidant balance is important in the pathogenesis of pulmonary effects of cigarette smoke, we evaluated the effects of cigarette smoke, exercise training and both on the pulmonary oxidant–antioxidant balance in the lungs.

METHODS

Experimental groups

In all experiments, the Helsinki convention for use and care of animals was followed. Our protocol was approved by the ethical committee of the School of Medicine of the University of Sao Paulo (Sao Paulo, Brazil). Male C57BL/6 mice (6–8 weeks old) were divided at random into four groups (n=25–32 per group): 1) control; 2) exercise (submitted to treadmill training); 3) smoke (exposed to cigarette smoke) and 4) smoke+exercise (submitted to treadmill training and exposed to cigarette smoke). Animals were submitted to exercise training and exposed to cigarette smoke for 60 and 30 min·day−1, respectively, 5 days·week−1 for 24 weeks. The smoke+exercise group was initially submitted to the exercise protocol, the mice were allowed to rest for ≥60 min, then the exposure to cigarette smoke was started.

Cigarette smoke exposure protocol

Smoke exposure was performed in an inhalation chamber (28 L), with two inlets (for air and smoke), one outlet and a fan, for enhancing air and smoke mixture inside the box. Synthetic airflow in the first inlet was set at 2 L·min−1, and the second inlet received a synthetic airflow that passed through a Venturi System connected to a lit cigarette, suctioning the cigarette smoke and conducting it inside the box. The airflow rate in this second inlet could be changed, providing more or less smoke mixture to the box. After several measurements of carbon monoxide (CO) concentration inside the box, we set this flow rate at 1.5 L·min−1, which produced CO levels ranging from 250 to 350 ppm. Carboxyhaemoglobin concentration in smoke-exposed mice was kept at 10% (±1.3%). Animals were exposed to 12 (±1) commercially filtered cigarettes per day (0.8 mg of nicotine, 10 mg of tar and 10 mg of CO per cigarette) and total particulate matter concentration 354.8±50.3 μg·m−3·day−1. Mice allocated to cigarette smoke exposure groups were kept in the box maintaining these CO levels for 30 min·day−1, 5 days·week−1 for 24 weeks. Control mice were exposed to room air.

Treadmill aerobic training and test

Mice were initially adapted to the treadmill for 3 days (15 min·day−1, 25% inclination and 0.2 km·h−1). After that, a maximal exercise capacity test was performed with a 5-min warm-up (25% inclination and 0.2 km·h−1) followed by an increase in treadmill speed (0.1 km·h−1 every 2.5 min) until animal exhaustion, i.e. until they were not able to run even after 10 gentle mechanical stimuli [10]. The test was repeated four times: initially, and 8, 16 and 24 weeks after the beginning of the exposure to either cigarette smoke or room air. Body weight, speed and total test time reached for each mouse were registered. Maximal aerobic capacity (100%) was established as the speed reached by each animal. Mice were trained at a moderate intensity of exercise (50% of maximal speed) for 60 min·day−1, 5 days·week−1 for 24 weeks. Aerobic conditioning began on the same day as the beginning of cigarette smoke exposure and continued until the end of the 24th week. Both protocols were performed in the morning. The smoke+exercise group was initially submitted to the exercise protocol, then mice were allowed to rest for ≥60 min to allow respiratory frequency to return to basal (pre-exercise) values, then the exposure to cigarette smoke was started.

Respiratory mechanics evaluation

24 h after the end of the exposure protocol, mice were anaesthetised, tracheostomised and mechanically ventilated (n=10–15 per group) using a FlexiVent ventilator (Scireq, Montreal, QC, Canada). Using the forced oscillatory technique and a constant phase model [11], airway resistance (Raw), tissue damping (G) and tissue elastance (H) parameters were obtained. G and H were normalised to body weight [12].

Total cells, macrophages and ROS measurement in bronchoalveolar lavage

Immediately after lung mechanics measurements, mice were killed by exsanguination, and bronchoalveolar lavage (BAL) samples were collected after washing the lungs with 0.5 mL of sterile saline. This procedure was repeated three times. 400 μL of cell suspension was added to 10 μL of 5 mM luminol (5-amino-2,3-dihydro-1,4-phthalazinedione; Sigma Chemical Co., St Louis, MO, USA) prepared in dimethyl sulfoxide (DMSO; Sigma Chemical Co.). ROS production was measured by a chemiluminescence assay method using luminol as the probe and a luminometer (MicroBeta TriLux, version 4.7; Perkin Elmer Life Sciences, Turku, Finland) for 15 min [13]. The results were expressed as number of photons per minute per 104 cells per millilitre of BAL. The BAL fluid collected was centrifuged at 900×g for 8 min at 5°C, and the cell pellet was resuspended in 1 mL of physiological saline. Total cells were counted using a Neubauer haemocytometer chamber (Carl Roth, Karlsruhe, Germany) and differential cells (300 cells·slide−1) were evaluated by microscopic examination of BAL samples prepared in cytocentrifuge slides, stained with Diff Quick (Medion Diagnostics, Dündingen, Switzerland) [14].

Lung histology and immunohistochemistry

Lungs were fixed at a constant pressure (20 cmH2O), and 5-μm-thick sections of lung tissue were stained with haematoxylin and eosin to measure mean linear intercept, an indicator of mean diameter of airspaces, as described previously [15]. Sirius red staining [16] was performed to evaluate collagen fibres by image analysis. Lung tissue was also immunostained with the following antibodies using the biotin-streptavidin peroxidase method: anti-glutathione peroxidase (anti-GPx; goat polyclonal, 1:150), anti-CuZn superoxide dismutase (anti-CuZnSOD; goat polyclonal, 1:400), anti-MnSOD (goat polyclonal, 1:200), anti-matrix metalloproteinase 9 (anti-MMP9; goat polyclonal, 1:400), anti-tissue inhibitor of metalloproteinase 1 (anti-TIMP1; rabbit polyclonal, 1:250), anti-interleukin (IL)-10 (rabbit polyclonal, 1:200), anti-extracellular SOD (anti-ECSOD; goat polyclonal, 1:400), anti-monocyte chemotactic protein 1 (anti-MCP1; goat polyclonal, 1:3,500), anti-tumour necrosis factor-α (anti-TNF-α; goat polyclonal, 1:1,800), anti-IL-1 receptor antagonist (anti-IL-1ra; goat polyclonal, 1:500) (all Santa Cruz Biotechnology, Santa Cruz, CA, USA) and anti-8-isoprostane (goat polyclonal, 1:500; Oxford Biomedical Research, Rochester Hills, MI, USA). Secondary antibodies from the Vector ABC Kit Vectastain Anti-Rabbit or Vector ABC Kit Vectastain Anti-Goat, both diluted 1:500 (Vector Laboratories, Inc., Burlingame, CA, USA), were used for reactions. These secondary antibodies were also applied without primary antibody in positive and negative tissue samples, serving as controls. Positive cells immunostaining with GPx, CuZnSOD, MnSOD, MMP9, TIMP1, IL-10, MCP1, TNF-α and IL-1ra in the alveolar parenchyma were assessed using a 100-point grid with a known area (62,500 μm2 at ×400 magnification) attached to the microscope ocular. We counted the number of points hitting alveolar tissue in each field. The alveolar tissue area in each field was calculated according to the number of points hitting alveolar tissue, as a proportion of the total grid area. We then counted the number of positive cells within that alveolar tissue area and expressed the results as cells per 106 μm2 [17]. We also evaluated the volume proportion of 8-isoprostane- or ECSOD-positive area expressed as the percentage of the positively immunostained area in relation to the total area of alveolar tissue. It should be clarified that the areas of airways and large vessels were excluded from the total area counted for analysis.

Statistical analysis

Statistical analysis was performed using Sigma Stat 10 software (Systat Software, Inc., San Jose, CA, USA). Comparisons among groups were carried out by ANOVA followed by the Holm–Sidak method for parametric data, or by ANOVA on ranks followed by Dunn’s method for nonparametric data. Differences were considered significant at p<0.05.

RESULTS

Physical test: time and speed

Figure 1 shows that after 8 weeks of training, the time that the mice could exercise on the treadmill at maximal speed was significantly greater in the exercise and smoke+exercise groups compared to the groups that were not trained (control and smoke; p<0.001). Similar results were observed after 16 and 24 weeks of training (fig. 1a). Exposure to cigarette smoke did not influence the results of the exercise tests. In fact, there were no significant differences between control and smoke groups or between exercise and smoke+exercise groups. Similar results were observed when maximal speed reached by the mice during the treadmill test was examined (fig. 1b).

Figure 1–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1–

Results of the tests performed on the treadmill to evaluate the intensity of aerobic conditioning of the studied mice. Tests were performed before the beginning of the exposure to cigarette smoke (time 0) and after 8, 16 and 24 weeks of the protocol. a) Time that the mice could exercise in the treadmill; b) maximal speed reached by each mouse among the four experimental groups. Data are presented as means and sd. ***: p<0.001 comparing control and smoke with exercise and smoke+exercise.

Respiratory mechanics evaluation

Raw, G and H were computed (fig. 2). The values were normalised to body weight because the experimental groups that were trained presented greater body mass at the end of the experimental protocol (p<0.01 compared with control and smoke groups; data not shown) [14]. We did not observe significant differences in Raw values when the four experimental groups were compared (fig. 2a). Exposure to cigarette smoke resulted in lower values of G (p<0.01 compared with the two groups that were not exposed to smoke; fig. 2b). Physical conditioning did not influence this response. In contrast, H values were lower in the group exposed to cigarette smoke for 24 weeks (p<0.01 compared with the other three groups; fig. 2c) and this decrease was not observed in the smoke+exercise group.

Figure 2–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2–

a) Airway resistance (Raw), b) tissue damping (tissue resistance; G) and c) pulmonary elastance (H) obtained in the four experimental groups, after 24 weeks of the experimental protocol. Data are presented as means and sd. The values were normalised to body weight. #: p<0.01 compared with the two groups that were not exposed to smoke; ¶: p<0.01 compared with the other three groups.

Emphysema development and pulmonary parenchyma remodelling

Exposure to cigarette smoke for 6 months resulted in an increase in airspace size and rupture of alveolar septa: hallmarks of emphysema. We observed an increase in mean linear intercept in the two lung compartments in the group of mice exposed to cigarette smoke only (smoke group; p=0.003 and p=0.002 compared with the other three groups, for central and peripheral airspaces, respectively; fig. 3a–e). The group of mice exposed to cigarette smoke and submitted to the aerobic conditioning protocol (smoke+exercise group) did not show the increase in mean linear intercept compared with control and exercise groups.

Figure 3–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3–

a-–d) Representative photomicrographs of haematoxylin- and eosin-stained pulmonary parenchyma of a) control, b) exercise, c) smoke and d) smoke+exercise groups. e) Mean linear intercept measured in central and peripheral areas of the lungs. f–i) Representative photomicrographs of slices of lung parenchyma from the f) control, g) exercise, h) smoke and i) smoke+exercise groups, stained with Sirius red for collagen fibres (arrows). j) Percentage of the alveolar wall with collagen fibres. Scale bars: 50 μm. Data in e) and j) are presented as means and sd. #: p=0.003 compared with the other three groups; ¶: p=0.002 compared with the other three groups; ***: p<0.001 compared with the groups not exposed to cigarette smoke.

Exposure to cigarette smoke resulted in the remodelling of the alveolar wall (fig. 3f–j). There was a significant increase in collagen fibres in the lungs of mice that were exposed to cigarette smoke (p<0.001 compared with the groups not exposed to smoke). Physical training did not influence this response to cigarette smoke.

Leukocytes and ROS in BAL fluid

Exposure to cigarette smoke resulted in an increase in the number of macrophages in BAL (p<0.01 compared with the groups that were not exposed to smoke; fig. 4a). Exercise training did not influence this response. There were no significant differences in the numbers of neutrophils or lymphocytes in BAL among the four experimental groups (data not shown). Figure 4b shows the concentrations of ROS in BAL. Exposure to cigarette smoke increased the production of ROS (p=0.029 compared with control) and aerobic training significantly reduced ROS production (p=0.001 compared with control). The group of mice that were submitted to both exercise and cigarette smoke showed values of ROS similar to the group that exercised but was not exposed to smoke (p<0.001 compared with smoke group).

Figure 4–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4–

a) Number of macrophages in bronchoalveolar lavage (BAL) fluid. b) Concentration of reactive oxygen species in BAL. Data are presented as means and sd. #: p=0.001 compared with control; ¶: p=0.029 compared with control; **: p<0.01 compared with the groups not exposed to cigarette smoke (control and exercise); ***: p<0.001 compared with smoke group.

Immunohistochemical studies

Exposure to cigarette smoke resulted in increase in the amount of 8-isoprostane in lung parenchyma, and this increase was not observed in the smoke+exercise group (fig. 5). In fact, expression levels of 8-isoprostane in lung parenchyma were significantly greater in the smoke group compared with the other three groups (p<0.01).

Figure 5–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5–

a–d) Representative photomicrographs of slices of lungs from the a) control, b) exercise, c) smoke and d) smoke+exercise groups, immunostained with anti-8-isoprostane (arrows). e) Density of alveolar tissue immunostained with antibody against 8-isoprostane. Scale bars: 50 μm. Data are presented as means and sd. **: p<0.01 compared with the other three groups.

Exercise training resulted in an increase in the density of cells expressing GPx in alveolar walls (p<0.001 for exercise versus control and smoke groups; fig. 6a–e). The smoke+exercise group showed intermediate numbers of cells expressing GPx (p<0.001, p=0.008 and p=0.046 compared with exercise, smoke and control groups, respectively). Exposure to cigarette smoke reduced the density of cells in the alveolar walls positive for CuZnSOD, and exercise training inhibited this reduction (p<0.01 for the smoke group versus the other three groups; fig. 6f–j). Exposure to cigarette smoke and aerobic physical training did not change the density of alveolar wall cells positive for MnSOD and ECSOD (fig. 6k and l).

Figure 6–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6–

a–d) Representative photomicrographs of slices of lungs from a) control, b) exercise, c) smoke and d) smoke+exercise groups, immunostained with anti-glutathione peroxidase (anti-GPx; arrows). e) Density of cells expressing GPx in alveolar walls. f–i) Representative photomicrographs of slices of lungs from f) control, g) exercise, h) smoke and i) smoke+exercise groups, immunostained with anti-CuZn superoxide dismutase (anti-CuZnSOD). j) Density of cells in alveolar walls positive for CuZnSOD. k and l) Density of cells in alveolar walls positive for k) MnSOD and l) extracellular SOD (ECSOD). Scale bars: 50 μm. Data are presented as means and sd. #: p<0.001 compared with exercise group; ¶: p=0.008 compared with smoke group; +: p=0.046 compared with control group; **: p<0.01 compared with the other three groups; ***: p<0.001 compared with control and smoke groups.

Smoke exposure reduced the density of alveolar wall cells positive for TIMP1, and physical training inhibited this reduction (p<0.02 for smoke versus the other three groups; fig. 7a–e). Smoke exposure and aerobic physical training did not significantly change the density of cells in alveolar walls positive for MMP9 (fig. 7f).

Figure 7–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7–

a–d) Representative photomicrographs of slices of lungs from the a) control, b) exercise, c) smoke and d) smoke+exercise groups, immunostained with anti-tissue inhibitor of metalloproteinase 1 (anti-TIMP1). e) Density of cells in alveolar walls positive for TIMP1. f) Density of cells in alveolar walls positive for matrix metalloproteinase (MMP)9. Scale bars: 50 μm. Data are presented as means and sd. #: p<0.02 compared with the other three groups.

The smoke group had a lower density of IL-10-positive cells than both groups that exercised (p=0.013 and p=0.009 versus exercise and smoke+exercise groups, respectively; fig. 8a–e). Exposure to cigarette smoke increased the density of MCP1-positive cells in alveolar wall, and physical training inhibited this increase (p<0.01 for smoke versus the other three groups; fig. 8f–j). There was a trend for a higher density of positive cells for TNF-α in the lungs of mice exposed to cigarette smoke (p=0.053; fig. 8k), but no statistically significant differences in the expression of IL-1ra in the lungs of mice of the four experimental groups (p=0.09; fig. 8l).

Figure 8–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 8–

a–d) Representative photomicrographs of slices of lungs from the a) control, b) exercise, c) smoke and d) smoke+exercise groups, immunostained with anti-interleukin (IL)-10. e) Density of cells in alveolar walls positive for IL-10. f–i) Representative photomicrographs of slices of lungs from the f) control, g) exercise, h) smoke and i) smoke+exercise groups, immunostained with anti-monocyte chemotactic protein (MCP)1. j–l) Density of cells positive for j) MCP1 in alveolar walls, k) tumour necrosis factor (TNF)-α and l) IL-1 receptor antagonist (IL-1ra). Scale bars: 50 μm. Data are presented as means and sd. #: p=0.013 compared with exercise group; ¶: p=0.009 compared with smoke+exercise group; **: p<0.01 compared with the other three groups.

DISCUSSION

In this study, we showed that aerobic physical training of moderate intensity reduces oxidative stress and protects against emphysema development induced by cigarette smoke exposure in mice. Exercise training inhibited the increase in mean linear intercept and the decrease in pulmonary elastance induced by cigarette smoke but did not affect collagen fibre remodeling. In addition, we observed a reduction in the production of ROS in BAL, lower accumulation of 8-isoprosane in pulmonary tissue, and an increase in the expression of antioxidant enzymes GPx and CuZnSOD induced by exercise training. These results suggest that aerobic training has a protective effect on the imbalance between oxidants and antioxidants involved in the pathogenesis of cigarette smoke-induced pulmonary disease.

There are many previous studies evaluating the effects of exercise training or cigarette smoke exposure on the oxidant–antioxidant balance. However, only a few studies have aimed to evaluate the combined effects of exercise training and smoke. To our knowledge, our study was the first to evaluate the effects of exercise training on the development of emphysema during long-term (24 weeks’) cigarette smoke exposure and to evaluate the possible mechanisms of the protective effects of long-term regular exercise, including the expression of enzymes involved in the oxidant–antioxidant balance in the lungs.

The experimental model used in our study shared several features with human COPD, such as exposure to cigarette smoke being a risk factor, a reduction in lung elastance and the development of pulmonary emphysema [18].

It is well established that several months of exposure to cigarette smoke are required for mice to develop pulmonary emphysema (usually in the order of 24 weeks) [18]. The susceptibility of mice to this disease is dependent on the mouse strain [19]. C57BL/6 mice exposed to cigarette smoke for 24 weeks show enlargement of airspaces and a pulmonary histology similar to human emphysema [20]. A previous study showed a partial improvement in pulmonary alterations in C57BL/6 mice exposed to cigarette smoke for 2 months and subjected to swimming [21].

Interestingly, in our study, mice exposed to cigarette smoke did not perform worse in the physical tests when compared with mice not exposed to smoke. This probably occurred because the physiological changes present in experimental models of COPD induced by exposure to cigarette smoke mimic a mild form of the disease in humans [22].

We used the mean linear intercept as a marker of the degree of alveolar distension, and our results are consistent with the development of emphysema, similar to previous studies [21, 23]. We observed enlargement of airspaces in the two lung compartments, defined by the distance from the pleura to the airways, suggesting that the lesion that develops in the lung in this experimental model is diffuse.

In our protocol, the effects of cigarette smoke exposure were more intense in pulmonary parenchyma than in the airways. In fact, we did not observe a significant difference in Raw values between the control group and mice exposed to cigarette smoke and we did not observe an increase in the density of inflammatory cells in the airways of mice exposed to cigarette smoke (data not shown). In contrast, we found a decrease in H, suggesting a decrease of elastic recoil capacity, compatible with the functional profile of human pulmonary emphysema, and a decrease in G. Our protocol of aerobic physical training protected the mice from the decrease in H observed in mice exposed to cigarette smoke, which was probably secondary to the inhibition of alveolar wall destruction by exercise. In contrast, we did not observe an effect of aerobic training on G. Tissue resistance may be influenced by the amount of collagen fibres in alveolar walls, and aerobic conditioning did not have an effect on the amount of alveolar wall collagen. Collagen fibres are the most abundant fibres in alveolar walls and perhaps most critical for the mechanical properties of lung parenchyma [24]. Interestingly, in a protocol of short-term (2-month) exposure to cigarette smoke, Menegali et al. [21] did not observe an effect of daily swimming on the amount of proline in the lungs of C57BL/6 mice.

Although the pathogenesis of COPD remains incompletely understood, oxidant–antioxidant and protease–antiprotease imbalances and pulmonary inflammation are central processes associated with the development of this disease, but the participation of each of these mechanisms and how they interact are still unclear [7]. Previous studies have shown that chronic exercise training induces the activity of some antioxidant enzymes [25] and anti-inflammatory mediators [26].

We observed an increase in the total number of inflammatory cells and macrophages in BAL of mice exposed to cigarette smoke, corroborating previous studies [27]. The macrophages induced by substances in cigarettes may also secrete ROS and a chemotactic peptide for monocytes (MCP1) [28]. In our study, we observed a significant increase in MCP1 in mice exposed to cigarette smoke as described previously in BAL of smokers [29]. It was previously shown that some of the anti-inflammatory effects of physical training occur by reducing the levels of MCP1 [30, 31]. Despite the fact that exercise training did not modify the quantities of macrophages in BAL of mice exposed to cigarette smoke in our study, exercise reduced the expression of MCP1 by inflammatory cells in lung parenchyma induced by exposure to cigarette smoke. However, exercise training substantially inhibited ROS production in BAL of both control mice and mice exposed to cigarette smoke. In addition, the density of 8-isoprostane in lung parenchyma was increased in mice exposed to cigarette smoke, and exercise training inhibited this increase. Isoprostanes are prostaglandin-like compounds that are formed from the peroxidation of arachidonic acid and are considered accurate markers of oxidative stress in vivo. There is an increase in 8-isoprostanes in the urine of COPD patients [32].

It is possible that the decrease in ROS production in BAL and in the expression of 8-isoprostanes in pulmonary tissue were due to an increase in the activity of antioxidant enzymes. In fact, we observed an increase in the density of cells expressing the antioxidant enzyme GPx in the lungs of mice submitted to the exercise training protocol. Exercise training also reversed the decrease in the density of lung cells expressing CuZnSOD induced by cigarette smoke. GPx has a role in the protection against lipid peroxidation due to decomposition of lipid hydroperoxides [33], and SODs are the primary class of enzymes that initiate the process of detoxifying superoxide anions by converting them into hydrogen peroxide. It was previously shown that both GPx and SOD increase in skeletal muscle after exercise training [25].

In our study, exposure to cigarette smoke did not change the expression of GPx in the lung. Other studies did not show any appreciable changes in the GPx activity in lung tissue obtained from chronic smokers [34]. In contrast, in an experimental model of exposure to cigarette smoke, GPx activity was increased [35].

Aerobic exercise inhibited the reduction of CuZnSOD found in mice exposed to smoke, but the expression of ECSOD and MnSOD was not different in the four experimental groups. There are three mammalian SODs: SOD1, CuZnSOD, is located mainly in the cytosol of cells; mitochondrial MnSOD, or SOD2, is predominantly located in the mitochondria and the cytosol; and SOD3, or ECSOD, is present outside the cells, where it is bound to matrix proteins such as collagen [36]. Other studies showed a reduction in the total antioxidant activity of CuZnSOD in the airway epithelium of asthmatics [37] and an increase in the production of superoxide anions in these patients [38]. Despite the fact that excessive production of ROS, particularly superoxide anions, is implicated in the pathophysiology of COPD [7], we are not aware of previous reports showing the expression of CuZnSOD in this disease.

Rush et al. [39] observed an elevation of CuZnSOD in the aortic endothelium of trained guinea pigs, and, although the protein levels of MnSOD were not altered, the levels of p67phox, a subunit of the enzyme pro-oxidant NADPH (nicotinamide adenine dinucleotide phosphate) oxidase, was reduced by exercise.

Previous studies have shown that aerobic exercise can produce anti-inflammatory effects against allergic lung inflammation, and part of these effects are mediated by the release of the anti-inflammatory cytokines IL-10 and IL-1ra, and also by direct regulation of the release of IL-1β and tumour necrosis factor-α [10, 40]. The expression of IL-10, a potent anti-inflammatory cytokine, was reduced in our mice exposed to cigarette smoke, in contrast to the results of Guerassimov et al. [19]. In our study, this smoke-induced reduction was inhibited by exercise training. IL-10 modulates the expression of some cytokines, soluble mediators and cell surface molecules by cells of myeloid origin, influencing the ability to activate and sustain immune and inflammatory responses [41].

Inhalation of cigarette smoke can also lead to the secretion of MMP2, MMP9, MMP12, neutrophil elastase and cathepsins K, L and S by macrophages. Some studies suggest that pro-inflammatory stimuli induced by smoking may regulate the activity of MMP9 in COPD [42]. However, in our mice, the expression of MMP9 was not increased by exposure to smoke, but we found a decrease in TIMP1 in mice exposed to cigarette smoke that was reversed by aerobic exercise. A decrease in the release of TIMPs by alveolar macrophages in COPD has also been seen by Hirano et al. [43]. Some studies have shown that IL-10 suppresses the release of MMP9 from monocytes of patients with COPD and, at the same time, stimulates the release of its major endogenous inhibitor, TIMP1 [44]. It is likely that the imbalance between proteases and their macrophage antiproteases has a pathogenic role in our experimental model of emphysema.

Our study has some limitations. We did not evaluate the time-course of the development of pulmonary effects of cigarette smoke and the influence of exercise on the oxidant–antioxidant balance during the emphysema development. In addition, we did not evaluate the effects of both cigarette smoke and aerobic training on the skeletal muscles. Future studies should be performed to clarify these points.

Many benefits of exercise training in COPD patients have been previously shown. Exercise alleviates symptoms, improves quality of life, and decreases exacerbation episodes and the risk of respiratory mortality in COPD. Our study suggests that exercise training may be important not only in pulmonary rehabilitation in COPD but also as an adjuvant in the prevention and progression of pulmonary disease due to cigarette smoking.

In summary, we have shown that regular aerobic physical training of moderate intensity reduces oxidative stress and protects against the development of emphysema in mice. Exercise training inhibited the emphysema development by a significant decrease in oxidative stress, with reductions in ROS production in BAL and in 8-isoprostane expression in lung parenchyma, and with increases in antioxidant enzymes (GPx and CuZnSOD), TIMP1 and IL-10 in the inflammatory cells of the alveolar wall. These results support the hypothesis that the antioxidant effect of exercise combats cellular oxidative stress, which is induced by cigarette smoke and has an important role in COPD development.

Footnotes

  • Support Statement

    This work was supported by the following Brazilian scientific agencies: Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Laborató rios de Investigação Médica da Faculdade de Medicina da Universidade de São Paulo (LIMHC-FMUSP) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).

  • Statement of Interest

    None declared.

  • Received January 9, 2011.
  • Accepted June 13, 2011.
  • ©ERS 2012

REFERENCES

  1. ↵
    1. Menezes AM,
    2. Perez-Padilla R,
    3. Jardim JR,
    4. et al
    . Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366: 1875–1881.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Garcia-Aymerich J,
    2. Lange P,
    3. Benet M,
    4. et al
    . Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007; 175: 458–463.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Radak Z,
    2. Naito H,
    3. Kaneko T,
    4. et al
    . Exercise training decreases DNA damage and increases DNA repair and resistance against oxidative stress of proteins in aged rat skeletal muscle. Pflugers Arch 2002; 445: 273–278.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Radak Z,
    2. Chung HY,
    3. Goto S
    . Systemic adaptation to oxidative challenge induced by regular exercise. Free Radic Biol Med 2008; 44: 153–159.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Calabrese EJ,
    2. Baldwin LA
    . Hormesis: the dose-response revolution. Annu Rev Pharmacol Toxicol 2003; 43: 175–197.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Chapman KR,
    2. Mannino DM,
    3. Soriano JB,
    4. et al
    . Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 188–207.
    OpenUrlFREE Full Text
  7. ↵
    1. Cosio BG,
    2. Agustí A
    . Update in chronic obstructive pulmonary disease 2009. Am J Respir Crit Care Med 2010; 181: 655–660.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Church DF,
    2. Pryor WA
    . Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985; 64: 111–126.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Frei B,
    2. Forte TM,
    3. Ames BN,
    4. et al
    . Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid. Biochem J 1991; 277: 133–138.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Vieira RP,
    2. Claudino RC,
    3. Duarte AC,
    4. et al
    . Aerobic exercise decreases chronic allergic lung inflammation and airway remodeling in mice. Am J Respir Crit Care Med 2007; 176: 871–877.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Hantos Z,
    2. Daroczy B,
    3. Suki B,
    4. et al
    . Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol 1992; 72: 168–178.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Gomes RF,
    2. Shen X,
    3. Ramchandani R,
    4. et al
    . Comparative respiratory system mechanics in rodents. J Appl Physiol 2000; 89: 908–916.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Athayde KS,
    2. Cocuzza M,
    3. Agarwal A,
    4. et al
    . Development of normal reference values for seminal reactive oxygen species and their correlation with leukocytes and semen parameters in a fertile population. J Androl 2007; 28: 613–620.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Ramos DS,
    2. Olivo CR,
    3. Quirino Santos Lopes FD,
    4. et al
    . Low-intensity swimming training partially inhibits lipopolysaccharide-induced acute lung injury. Med Sci Sports Exerc 2010; 42: 113–119.
    OpenUrlPubMed
  15. ↵
    1. Takubo Y,
    2. Guerassimov A,
    3. Ghezzo H,
    4. et al
    . α1-antitrypsin determines the pattern of emphysema and function in tobacco smoke-exposed mice: parallels with human diseases. Am J Respir Crit Care Med 2002; 166: 1596–1603.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Dolhnikoff M,
    2. Mauad T,
    3. Ludwig MS
    . Extracellular matrix and oscillatory mechanics of rat lung parenchyma in bleomycin-induced fibrosis. Am J Respir Crit Care Med 1999; 160: 1750–1757.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. Simões SM,
    2. Santos MA,
    3. Oliveira MS,
    4. et al
    . Inflammatory cell mapping of the respiratory tract in fatal asthma. Clin Exp Allergy 2005; 35: 602–611.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Wright JL,
    2. Cosio M,
    3. Churg A
    . Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2008; 295: L1–L15.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Guerassimov A,
    2. Hoshino Y,
    3. Takubo Y,
    4. et al
    . The development of emphysema in cigarette smoke-exposed mice is strain dependent. Am J Respir Crit Care Med 2004; 170: 974–980.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Bartalesi B,
    2. Cavarra E,
    3. Fineschi S,
    4. et al
    . Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants. Eur Respir J 2005; 25: 15–22.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Menegali BT,
    2. Nesi RT,
    3. Souza PS,
    4. et al
    . The effects of physical exercise on the cigarette smoke-induced pulmonary oxidative response. Pulm Pharmacol Ther 2009; 22: 567–573.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Rabe KF,
    2. Hurd S,
    3. Anzueto A,
    4. et al
    . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532–555.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Kasagi S,
    2. Seyama K,
    3. Mori H,
    4. et al
    . Tomato juice prevents senescence-accelerated mouse P1 strain from developing emphysema induced by chronic exposure to tobacco smoke. Am J Physiol Lung Cell Mol Physiol 2006; 290: L396–L404.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Suki B,
    2. Ito S,
    3. Stamenovic D,
    4. et al
    . Biomechanics of the lung parenchyma: critical roles of collagen and mechanical forces. J Appl Physiol 2005; 98: 1892–1899.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Ji LL
    . Modulation of skeletal muscle antioxidant defense by exercise: role of redox signaling. Free Radic Biol Med 2008; 44: 142–152.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. Petersen AM,
    2. Pedersen BK
    . The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98: 1154–1162.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Finkelstein R,
    2. Fraser RS,
    3. Ghezzo H,
    4. et al
    . Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995; 152: 1666–1672.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    1. Barnes PJ,
    2. Shapiro SD,
    3. Pauwels RA
    . Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22: 672–688.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Capelli A,
    2. Di Stefano A,
    3. Gnemmi I,
    4. et al
    . Increased MCP-1 and MIP-1β in bronchoalveolar lavage fluid of chronic bronchitics. Eur Respir J 1999; 14: 160–165.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Trøseid M,
    2. Lappegård KT,
    3. Claudi T,
    4. et al
    . Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome. Eur Heart J 2004; 25: 349–355.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Adamopoulos S,
    2. Parissis J,
    3. Kroupis C,
    4. et al
    . Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J 2001; 22: 791–797.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    1. Pratico D,
    2. Basili S,
    3. Vieri M,
    4. et al
    . Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2α-III, an index of oxidant stress. Am J Respir Crit Care Med 1998; 158: 1709–1714.
    OpenUrlCrossRefPubMedWeb of Science
  33. ↵
    1. Federico A,
    2. Morgillo F,
    3. Tuccillo C,
    4. et al
    . Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 2007; 121: 2381–2386.
    OpenUrlCrossRefPubMedWeb of Science
  34. ↵
    1. Pasquini R,
    2. Sforzolini GS,
    3. Cavaliere A,
    4. et al
    . Enzymatic activities of human lung tissue: relationship with smoking habits. Carcinogenesis 1988; 9: 1411–1416.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    1. York GK,
    2. Peirce TH,
    3. Schwartz LW,
    4. et al
    . Stimulation by cigarette smoke of glutathione peroxidase system enzyme activities in rat lung. Arch Environ Health 1976; 31: 286–290.
    OpenUrlPubMedWeb of Science
  36. ↵
    1. Kinnula VL,
    2. Crapo JD
    . Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med 2003; 167: 1600–1619.
    OpenUrlCrossRefPubMedWeb of Science
  37. ↵
    1. Smith LJ,
    2. Shamsuddin M,
    3. Sporn PH,
    4. et al
    . Reduced superoxide dismutase in lung cells of patients with asthma. Free Radic Biol Med 1997; 22: 1301–1307.
    OpenUrlCrossRefPubMedWeb of Science
  38. ↵
    1. Jarjour NN,
    2. Busse WW,
    3. Calhoun WJ
    . Enhanced production of oxygen radicals in nocturnal asthma. Am Rev Respir Dis 1992; 146: 905–911.
    OpenUrlPubMedWeb of Science
  39. ↵
    1. Rush JW,
    2. Turk JR,
    3. Laughlin MH
    . Exercise training regulates SOD-1 and oxidative stress in porcine aortic endothelium. Am J Physiol Heart Circ Physiol 2003; 284: H1378–H1387.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Chen HI,
    2. Hsieh SY,
    3. Yang FL,
    4. et al
    . Exercise training attenuates septic responses in conscious rats. Med Sci Sports Exerc 2007; 39: 435–442.
    OpenUrlCrossRefPubMedWeb of Science
  41. ↵
    1. Moore KW,
    2. de Waal Malefyt R,
    3. Coffman RL,
    4. et al
    . Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683–765.
    OpenUrlCrossRefPubMedWeb of Science
  42. ↵
    1. Finlay GA,
    2. O'Driscoll LR,
    3. Russell KJ,
    4. et al
    . Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997; 156: 240–247.
    OpenUrlCrossRefPubMedWeb of Science
  43. ↵
    1. Hirano K,
    2. Sakamoto T,
    3. Uchida Y,
    4. et al
    . Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Eur Respir J 2001; 18: 748–752.
    OpenUrlAbstract/FREE Full Text
  44. ↵
    1. Lacraz S,
    2. Nicod LP,
    3. Chicheportiche R,
    4. et al
    . IL10 inhibits metalloproteinase and stimulates TIMP1 production in human mononuclear phagocytes. J Clin Invest 1995; 96: 2304–2310.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 39 Issue 2 Table of Contents
European Respiratory Journal: 39 (2)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Aerobic exercise attenuates pulmonary injury induced by exposure to cigarette smoke
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Aerobic exercise attenuates pulmonary injury induced by exposure to cigarette smoke
A.C. Toledo, R.M. Magalhaes, D.C. Hizume, R.P. Vieira, P.J.C. Biselli, H.T. Moriya, T. Mauad, F.D.T.Q.S. Lopes, M.A. Martins
European Respiratory Journal Feb 2012, 39 (2) 254-264; DOI: 10.1183/09031936.00003411

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Aerobic exercise attenuates pulmonary injury induced by exposure to cigarette smoke
A.C. Toledo, R.M. Magalhaes, D.C. Hizume, R.P. Vieira, P.J.C. Biselli, H.T. Moriya, T. Mauad, F.D.T.Q.S. Lopes, M.A. Martins
European Respiratory Journal Feb 2012, 39 (2) 254-264; DOI: 10.1183/09031936.00003411
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Lung structure and function
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Article

  • Lung volumes and survival in chronic lung allograft dysfunction
  • PH due to hypoventilation and effect of noninvasive ventilation
  • Prediction of new-onset asthma and nasal allergy
Show more Original Article

Smoking-Related Disorders

  • smoking-related disorders
  • smoking-related disorders
Show more Smoking-Related Disorders

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society